Clinical Chemistry and Immunodiagnostics Market 2014 Opportunities Forecast & Analyzed in New Research Report

2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostic Market is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.
Complete report is spread across 1115 pages is available @ http://www.reportsnreports.com/reports/268515-2014-opportunities-in-the-global-clinical-chemistry-and-immunodiagnostics-markets.html.
Rationale
The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Worldwide Market Overview
• Estimates of facilities performing clinical chemistry and immunodiagnostic tests by country.
• Test volume and sales projections by country.
Strategic Recommendations
• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
Competitive Assessments
• Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
• The companies analyzed in the report include Abbott, AdnaGen, Agilent, Alere, Beckman Coulter/Danaher,Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin,
• Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex,Ortho-Clinical Diagnotics, Roche, Siemens, Sysmex,Thermo Fisher, Tosoh, Wako, Wallac/PE.
Tests Analyzed in the Report:
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone,Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),Propoxyphene, Tricyclic Antidepressants.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=268515.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Market Segmentation Analysis
• Comprehensive review of the market dynamics, trends, structure, size, growth,and key suppliers, by country.
• Test volume and sales forecasts for over 100 clinical chemistry,TDM, endocrine, cancer, immunoprotein and abused drug assays,by country and market segment:
o Hospitals
o Commercial/Private Laboratories
o Physician Offices/Group Practices
o Ambulatory Care Centers
Current and Emerging Products
• Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
• Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
Technology Review
• Assessment of current and emerging technologies, and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and products by test.

Major Points from Table of Contents for 2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Market:
1. Introduction
2. Worldwide Market and Technology Overview
3. France
4. Germany
5. Italy
6. Japan
7. Spain
8. U.K.
9. U.S.A.
10. Major Product Development Opportunities
11. Design Criteria for Decentralized Testing Products
12. Alternative Market Penetration Strategies
13. Potential Market Entry Barriers and Risks
14. Competitive Assessments
15. List of Tables
16. Major Companies Developing or Marketing Albumin Tests
17. Executive Summary Table: France, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
18. Executive Summary Table: Germany, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
19. Executive Summary Table: Italy, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
20. Executive Summary Table: Japan, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
21. Executive Summary Table: Spain, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
22. Executive Summary Table: U.K., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
23. Executive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category

ReportsandReports is an online market research reports library of 350,000 plus in-depth studies of over 5000 micro markets. Call 18883915441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need.

ReportsandReports
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
call :+ 1 888 391 5441

This release was published on openPR.